Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1997;90(Suppl 31):13–20. doi: 10.1177/014107689709031s04

Joint disorders in cystic fibrosis.

M A Turner 1, E Baildam 1, L Patel 1, T J David 1
PMCID: PMC1296093  PMID: 9204006

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Ogle J. W., Harbeck R. J., Butler-Simon N., Hammond K. B., Accurso F. J. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991 Aug;119(2):211–217. doi: 10.1016/s0022-3476(05)80729-2. [DOI] [PubMed] [Google Scholar]
  2. Aricò M., Bossi G., Caselli D., Cosi G., Villa A., Beluffi G., Genovese E. Long-term magnetic resonance survey of cartilage damage in leukemic children treated with fluoroquinolones. Pediatr Infect Dis J. 1995 Aug;14(8):713–714. doi: 10.1097/00006454-199508000-00014. [DOI] [PubMed] [Google Scholar]
  3. Barland P., Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med. 1996 Feb 26;100(2A):16S–23S. doi: 10.1016/s0002-9343(97)89542-3. [DOI] [PubMed] [Google Scholar]
  4. Benjamin C. M., Clague R. B. Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management. Br J Rheumatol. 1990 Aug;29(4):301–302. doi: 10.1093/rheumatology/29.4.301. [DOI] [PubMed] [Google Scholar]
  5. Bourke S., Rooney M., Fitzgerald M., Bresnihan B. Episodic arthropathy in adult cystic fibrosis. Q J Med. 1987 Aug;64(244):651–659. [PubMed] [Google Scholar]
  6. Burmester G. R., Daser A., Kamradt T., Krause A., Mitchison N. A., Sieper J., Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. doi: 10.1146/annurev.iy.13.040195.001305. [DOI] [PubMed] [Google Scholar]
  7. Burmester G. R., Daser A., Kamradt T., Krause A., Mitchison N. A., Sieper J., Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. doi: 10.1146/annurev.iy.13.040195.001305. [DOI] [PubMed] [Google Scholar]
  8. Calabrese L. H., Duna G. F. Evaluation and treatment of central nervous system vasculitis. Curr Opin Rheumatol. 1995 Jan;7(1):37–44. [PubMed] [Google Scholar]
  9. Careless D. J., Inman R. D. Etiopathogenesis of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol. 1995 Jul;7(4):290–298. doi: 10.1097/00002281-199507000-00005. [DOI] [PubMed] [Google Scholar]
  10. Church J. A., Jordan S. C., Keens T. G., Wang C. I. Circulating immune complexes in patients with cystic fibrosis. Chest. 1981 Oct;80(4):405–411. doi: 10.1378/chest.80.4.405. [DOI] [PubMed] [Google Scholar]
  11. Cid M. C. New developments in the pathogenesis of systemic vasculitis. Curr Opin Rheumatol. 1996 Jan;8(1):1–11. doi: 10.1097/00002281-199601000-00001. [DOI] [PubMed] [Google Scholar]
  12. Coffey M., Hassan J., Feighery C., Fitzgerald M., Bresnihan B. Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections. Clin Exp Immunol. 1989 Jul;77(1):52–57. [PMC free article] [PubMed] [Google Scholar]
  13. Danisovicová A., Brezina M., Belan S., Kayserová H., Kaiserová E., Hruskovic I., Orosová K., Dluholucký S., Galova K., Mathéova E. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy. 1994 May-Jun;40(3):209–214. doi: 10.1159/000239194. [DOI] [PubMed] [Google Scholar]
  14. Davis C. A., Abramowsky C. R., Swinehart G. Circulating immune complexes and the nephropathy of cystic fibrosis. Hum Pathol. 1984 Mar;15(3):244–247. doi: 10.1016/s0046-8177(84)80187-2. [DOI] [PubMed] [Google Scholar]
  15. Dickinson C. J. The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest. 1993 Jun;23(6):330–338. doi: 10.1111/j.1365-2362.1993.tb02032.x. [DOI] [PubMed] [Google Scholar]
  16. Disis M. L., McDonald T. L., Colombo J. L., Kobayashi R. H., Angle C. R., Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res. 1986 May;20(5):385–390. doi: 10.1203/00006450-198605000-00002. [DOI] [PubMed] [Google Scholar]
  17. Dixey J., Redington A. N., Butler R. C., Smith M. J., Batchelor J. R., Woodrow D. F., Hodson M. E., Batten J. C., Brewerton D. A. The arthropathy of cystic fibrosis. Ann Rheum Dis. 1988 Mar;47(3):218–223. doi: 10.1136/ard.47.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Exley A. R., Bacon P. A. Clinical disease activity in systemic vasculitis. Curr Opin Rheumatol. 1996 Jan;8(1):12–18. doi: 10.1097/00002281-199601000-00002. [DOI] [PubMed] [Google Scholar]
  19. Finnegan M. J., Hinchcliffe J., Russell-Jones D., Neill S., Sheffield E., Jayne D., Wise A., Hodson M. E. Vasculitis complicating cystic fibrosis. Q J Med. 1989 Jul;72(267):609–621. [PubMed] [Google Scholar]
  20. Fradin M. S., Kalb R. E., Grossman M. E. Recurrent cutaneous vasculitis in cystic fibrosis. Pediatr Dermatol. 1987 Aug;4(2):108–111. doi: 10.1111/j.1525-1470.1987.tb00763.x. [DOI] [PubMed] [Google Scholar]
  21. Garty B. Z., Scanlin T., Goldsmith D. P., Grunstein M. Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins. Br J Dermatol. 1989 Nov;121(5):655–658. doi: 10.1111/j.1365-2133.1989.tb08199.x. [DOI] [PubMed] [Google Scholar]
  22. Gross W. L., Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol. 1995 Jan;7(1):11–19. [PubMed] [Google Scholar]
  23. Hodson M. E., Beldon I., Batten J. C. Circulating immune complexes in patients with cystic fibrosis in relation to clinical features. Clin Allergy. 1985 Jul;15(4):363–370. doi: 10.1111/j.1365-2222.1985.tb03004.x. [DOI] [PubMed] [Google Scholar]
  24. Hodson M. E. Vasculitis and arthropathy in cystic fibrosis. J R Soc Med. 1992;85 (Suppl 19):38–40. [PMC free article] [PubMed] [Google Scholar]
  25. Johnson S., Knox A. J. Arthropathy in cystic fibrosis. Respir Med. 1994 Sep;88(8):567–570. doi: 10.1016/s0954-6111(05)80003-4. [DOI] [PubMed] [Google Scholar]
  26. Jones M. M., Seilheimer D. K., Pollack M. S., Curry M., Crane M. M., Rossen R. D. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis. 1989 Dec;140(6):1636–1639. doi: 10.1164/ajrccm/140.6.1636. [DOI] [PubMed] [Google Scholar]
  27. Keogan M. T., Callaghan M., Yanni G., Mulherin D., Feighery C., Brown D. L., Fitzgerald M. X., Bresnihan B. Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels. Clin Exp Immunol. 1993 Mar;91(3):462–466. doi: 10.1111/j.1365-2249.1993.tb05925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients--review. Infection. 1993 Nov-Dec;21(6):413–421. doi: 10.1007/BF01728929. [DOI] [PubMed] [Google Scholar]
  29. Lomaestro B. M., Bailie G. R. Quinolone-cation interactions: a review. DICP. 1991 Nov;25(11):1249–1258. doi: 10.1177/106002809102501115. [DOI] [PubMed] [Google Scholar]
  30. Manthei U., Taussig L. M., Beckerman R. C., Strunk R. C. Circulating immune complexes in cystic fibrosis. Am Rev Respir Dis. 1982 Aug;126(2):253–257. doi: 10.1164/arrd.1982.126.2.253. [DOI] [PubMed] [Google Scholar]
  31. Moss R. B., Hsu Y. P., Lewiston N. J., Curd J. G., Milgrom H., Hart S., Dyer B., Larrick J. W. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am Rev Respir Dis. 1986 Apr;133(4):648–652. doi: 10.1164/arrd.1986.133.4.648. [DOI] [PubMed] [Google Scholar]
  32. Pertuiset E., Lenoir G., Jehanne M., Douchain F., Guillot M., Menkès C. J. Tolérance articulaire de la péfloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev Rhum Mal Osteoartic. 1989 Nov;56(11):735–740. [PubMed] [Google Scholar]
  33. Pertuiset E., Menkes C. J., Lenoir G., Jehanne M., Douchain F., Guillot M. Cystic fibrosis arthritis. A report of five cases. Br J Rheumatol. 1992 Aug;31(8):535–538. doi: 10.1093/rheumatology/31.8.535. [DOI] [PubMed] [Google Scholar]
  34. Phillips B. M., David T. J. Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med. 1986;79 (Suppl 12):44–50. [PMC free article] [PubMed] [Google Scholar]
  35. Pineda C. Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheumatol. 1992 May-Jun;10 (Suppl 7):27–33. [PubMed] [Google Scholar]
  36. Pitcher-Wilmott R. W., Levinsky R. J., Matthew D. J. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis. Arch Dis Child. 1982 Aug;57(8):577–581. doi: 10.1136/adc.57.8.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pope R. M. Rheumatoid arthritis: pathogenesis and early recognition. Am J Med. 1996 Feb 26;100(2A):3S–9S. doi: 10.1016/s0002-9343(97)89540-x. [DOI] [PubMed] [Google Scholar]
  38. Rush P. J., Shore A., Coblentz C., Wilmot D., Corey M., Levison H. The musculoskeletal manifestations of cystic fibrosis. Semin Arthritis Rheum. 1986 Feb;15(3):213–225. doi: 10.1016/0049-0172(86)90018-1. [DOI] [PubMed] [Google Scholar]
  39. Samuelson W. M., Pleasants R. A., Whitaker M. S. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. Ann Pharmacother. 1993 Mar;27(3):302–303. doi: 10.1177/106002809302700308. [DOI] [PubMed] [Google Scholar]
  40. Schaad U. B., Stoupis C., Wedgwood J., Tschaeppeler H., Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J. 1991 Oct;10(10):723–729. [PubMed] [Google Scholar]
  41. Schaad U. B., abdus Salam M., Aujard Y., Dagan R., Green S. D., Peltola H., Rubio T. T., Smith A. L., Adam D. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J. 1995 Jan;14(1):1–9. doi: 10.1097/00006454-199501000-00001. [DOI] [PubMed] [Google Scholar]
  42. Schidlow D. V., Panitch H. B., Zaeri N., Zenel J., Alpert B. E. Purpuric rashes in cystic fibrosis. Am J Dis Child. 1989 Sep;143(9):1030–1032. doi: 10.1001/archpedi.1989.02150210056018. [DOI] [PubMed] [Google Scholar]
  43. Soden M., Tempany E., Bresnihan B. Sarcoid arthropathy in cystic fibrosis. Br J Rheumatol. 1989 Aug;28(4):341–343. doi: 10.1093/rheumatology/28.4.341. [DOI] [PubMed] [Google Scholar]
  44. Stahlmann R., Förster C., Shakibaei M., Vormann J., Günther T., Merker H. J. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother. 1995 Sep;39(9):2013–2018. doi: 10.1128/aac.39.9.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stahlmann R., Merker H. J., Hinz N., Chahoud I., Webb J., Heger W., Neubert D. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol. 1990;64(3):193–204. doi: 10.1007/BF02010725. [DOI] [PubMed] [Google Scholar]
  46. Szer I. S. Henoch-Schönlein purpura. Curr Opin Rheumatol. 1994 Jan;6(1):25–31. doi: 10.1097/00002281-199401000-00005. [DOI] [PubMed] [Google Scholar]
  47. Tomashefski J. F., Jr, Abramowsky C. R., Chung-Park M., Wisniewska J., Bruce M. C. Immunofluorescence studies of lung tissue in cystic fibrosis. Pediatr Pathol. 1992 May-Jun;12(3):313–324. doi: 10.3109/15513819209023312. [DOI] [PubMed] [Google Scholar]
  48. Wisnieski J. J., Todd E. W., Fuller R. K., Jones P. K., Dearborn D. G., Boat T. F., Naff G. B. Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway. Am Rev Respir Dis. 1985 Oct;132(4):770–776. doi: 10.1164/arrd.1985.132.4.770. [DOI] [PubMed] [Google Scholar]
  49. Wulffraat N. M., de Graeff-Meeder E. R., Rijkers G. T., van der Laag H., Kuis W. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr. 1994 Sep;125(3):374–378. doi: 10.1016/s0022-3476(05)83279-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES